Management of Metabolic Acidosis in CKD
For patients with CKD and GFR ≤30 ml/min/1.73 m², maintain serum bicarbonate ≥22 mmol/L using oral sodium bicarbonate 25-50 mEq/day (2-4 g/day), with monitoring every 3 months. 1
Monitoring Strategy
Frequency of Bicarbonate Measurement
- GFR ≤30 ml/min/1.73 m²: Check serum bicarbonate every 3 months 1
- Maintenance dialysis patients: Check monthly 2
The rationale is straightforward: metabolic acidosis in CKD drives protein catabolism, increases branched-chain amino acid oxidation, decreases albumin synthesis, and accelerates CKD progression 2. Regular monitoring catches acidosis before these complications manifest.
Treatment Thresholds and Targets
When to Treat
The evidence here has evolved significantly. Traditional guidelines recommended treatment when bicarbonate falls below 22 mmol/L 1. However, the 2024 KDIGO guidelines have shifted to a more conservative approach, recommending pharmacological treatment only when bicarbonate drops below 18 mmol/L 3, 4. This change reflects recent trial data showing that routine bicarbonate supplementation at higher thresholds may not improve outcomes and could cause harm.
Target Bicarbonate Level
- Traditional target: ≥22 mmol/L 2, 1
- Upper limit: Do not exceed normal range (typically <28-30 mmol/L) 3, 4
Critical caveat: While observational data suggested targeting bicarbonate near 28 mmol/L might improve outcomes, the CRIC study found values >26 mmol/L associated with incident heart failure and mortality 5. Additionally, overcorrection may provoke vascular calcification 5. Therefore, aim for 22-26 mmol/L range, avoiding both extremes.
Oral Alkali Dosing
Sodium Bicarbonate
- Starting dose: 25-50 mEq/day (2-4 g/day) 2
- Typical maintenance: 1.09-1.13 mmol/kg/day 6
- Administration: Divide into 2-3 doses daily to improve tolerance
The UBI study demonstrated that this dosing safely improves kidney and patient survival over 36 months without significantly affecting blood pressure, body weight, or hospitalizations 6.
Dialysate Adjustment (for dialysis patients)
- Hemodialysis: Increase dialysate bicarbonate to 38 mmol/L 2
- Peritoneal dialysis: Increase dialysate lactate or bicarbonate levels 2
Dietary Recommendations
Reduce dietary acid load by 50% through increased consumption of base-producing fruits and vegetables while limiting animal-sourced protein 7, 8. This approach is particularly valuable for patients with contraindications to sodium bicarbonate or those concerned about sodium load.
The evidence supporting dietary intervention is compelling: a randomized trial showed that fruits and vegetables reduced urine angiotensinogen (a marker of kidney angiotensin II activity) and preserved eGFR comparably to sodium bicarbonate in stage 3 CKD patients with bicarbonate 22-24 mmol/L 7.
Specific Dietary Guidance
- Increase: Fruits and vegetables (base-producing foods)
- Limit: Animal-sourced protein (acid-producing foods) 8
- Note: Low phosphorus diets (800-1000 mg/day) recommended for CKD patients inherently limit protein, which reduces acid load 1
Monitoring During Treatment
Monitor the following parameters to prevent complications from alkali therapy 3, 4:
- Serum bicarbonate: Ensure it doesn't exceed upper limit of normal
- Blood pressure: Watch for worsening hypertension from sodium load
- Serum potassium: Risk of hypokalemia with alkali therapy
- Fluid status: Assess for edema from sodium retention
These monitoring parameters are critical because sodium bicarbonate provides a significant sodium load (1 g sodium bicarbonate = 12 mEq sodium), which can exacerbate hypertension and fluid overload in CKD patients.
Benefits of Correction
Correcting metabolic acidosis provides multiple benefits 2:
- Increased serum albumin
- Decreased protein degradation
- Increased plasma branched-chain amino acids
- Improved body weight and mid-arm circumference
- Reduced hospitalizations (demonstrated in peritoneal dialysis patients)
- Slowed CKD progression 6, 7
Indications for Dialysis
While metabolic acidosis itself is not an absolute indication for dialysis initiation, severe refractory acidosis (bicarbonate <15 mmol/L) despite maximal medical therapy represents one component of the uremic syndrome that may prompt dialysis consideration. This decision should be made in context with other uremic complications, volume status, and patient symptoms.
Common Pitfalls
- Overcorrection: Targeting bicarbonate >26 mmol/L may increase cardiovascular risk 5
- Ignoring sodium load: Each gram of sodium bicarbonate contains 12 mEq sodium—monitor for hypertension and edema
- Treating subclinical acidosis (bicarbonate 22-24 mmol/L) routinely: Recent guidelines suggest this may not benefit all patients 3, 4
- Neglecting dietary approaches: Fruits and vegetables can be as effective as sodium bicarbonate without sodium load 7
Algorithm for Management
Step 1: Measure serum bicarbonate every 3 months in patients with GFR ≤30 ml/min/1.73 m²
Step 2: If bicarbonate <18 mmol/L → Initiate sodium bicarbonate 25-50 mEq/day OR dietary acid reduction with fruits/vegetables
Step 3: If bicarbonate 18-22 mmol/L → Consider dietary intervention first; add sodium bicarbonate if dietary measures insufficient
Step 4: Monitor bicarbonate, BP, potassium, and fluid status monthly after initiating treatment
Step 5: Titrate dose to maintain bicarbonate 22-26 mmol/L, avoiding values >26 mmol/L
Step 6: Once stable, continue monitoring bicarbonate every 3 months